Pierre Fouret Selected Research

Pierre Fouret Research Topics

Disease

11	Neoplasms (Cancer) 01/2017 - 09/2003
5	Lung Neoplasms (Lung Cancer) 01/2017 - 09/2006
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017 - 09/2006
4	Adenocarcinoma of Lung 03/2014 - 07/2008
2	Fibrosis (Cirrhosis) 01/2022 - 01/2002
2	Cardiogenic Shock 01/2021 - 01/2018
2	Myocardial Infarction 01/2021 - 01/2002
2	Heart Failure 01/2020 - 01/2002
2	Giant Cell Arteritis (Horton Disease) 01/2020 - 06/2012
2	Arrhythmogenic Right Ventricular Dysplasia (Arrhythmogenic Right Ventricular Cardiomyopathy) 11/2014 - 01/2013
2	Adenoid Cystic Carcinoma (Cylindroma) 11/2009 - 11/2008
2	Mucoepidermoid Carcinoma 11/2006 - 07/2005
1	Poisoning 01/2021
1	Sarcoidosis (Schaumann Disease) 01/2020
1	Granuloma 01/2020
1	Vasculitis (Vasculitides) 01/2020
1	Septic Shock (Toxic Shock Syndrome) 01/2018
1	Cardiomyopathies (Cardiomyopathy) 01/2018
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2018
1	Pdgfra-Associated Chronic Eosinophilic Leukemia 11/2015
1	Endomyocardial Fibrosis 11/2015
1	Ventricular Tachycardia 11/2014
1	Polymorphic catecholergic ventricular tachycardia 11/2014
1	Adenocarcinoma 03/2014
1	Disease Progression 02/2013
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2013
1	Pathologic Constriction (Stenosis) 08/2012
1	Squamous Cell Carcinoma of Head and Neck 07/2007
1	Hypertrophy 01/2002

Drug/Important Bio-Agent (IBA)

8	Cisplatin (Platino)FDA LinkGeneric 02/2013 - 09/2006
4	Proteins (Proteins, Gene)FDA Link 01/2017 - 09/2006
3	Phosphotransferases (Kinase)IBA 11/2008 - 11/2006
2	CytokinesIBA 01/2020 - 01/2002
2	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 03/2014
2	p38 Mitogen-Activated Protein KinasesIBA 10/2012 - 07/2008
2	Mitogen-Activated Protein KinasesIBA 11/2008 - 07/2008
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 07/2008 - 09/2003
1	Collagen Type I (Type I Collagen)IBA 01/2022
1	Fibronectins (Fibronectin)IBA 01/2022
1	Colchicine FDA LinkGeneric 01/2021
1	Interleukin-33IBA 01/2020
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2017
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2017
1	A-Form DNA (A-DNA)IBA 01/2017
1	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 11/2014
1	Formaldehyde (Formol)FDA Link 03/2014
1	ParaffinIBA 03/2014
1	Tumor Suppressor Protein p14ARF (p14ARF)IBA 03/2014
1	gamma Catenin (Plakoglobin)IBA 01/2013
1	CateninsIBA 01/2013
1	Desmosomal CadherinsIBA 01/2013
1	Messenger RNA (mRNA)IBA 10/2012
1	Adenosine Triphosphatases (ATPase)IBA 10/2012
1	Cytotoxins (Cytolysins)IBA 08/2012
1	Glutathione (Reduced Glutathione)IBA 08/2012
1	Vitamin B 6IBA 08/2012
1	interleukin-21 (interleukin 21)IBA 06/2012
1	Biomarkers (Surrogate Marker)IBA 01/2011
1	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 01/2011
1	Docetaxel (Taxotere)FDA Link 11/2009
1	EnzymesIBA 07/2008
1	SB 203580IBA 07/2008
1	OligonucleotidesIBA 05/2008
1	Cyclin D1IBA 05/2008
1	MucinsIBA 07/2005
1	Alcian BlueIBA 07/2005
1	Cyclin AIBA 09/2003
1	salicylhydroxamic acid (SHAM)IBA 01/2002
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2002
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2002
1	CatecholaminesIBA 01/2002

Therapy/Procedure

4	Drug Therapy (Chemotherapy) 01/2017 - 09/2006
2	Heart Transplantation (Grafting, Heart) 01/2020 - 11/2015
2	Adjuvant Chemotherapy 02/2010 - 09/2006
1	Transplantation 01/2020
1	Extracorporeal Membrane Oxygenation 01/2018
1	Precision Medicine 01/2017
1	Therapeutics 02/2013
1	Bioprosthesis 08/2012
1	Radiotherapy 11/2009
1	Aftercare (After-Treatment) 07/2008
1	Induction Chemotherapy 07/2007
1	Ligation 01/2002